ASUNCIÓN LÓPEZ-CALDERÓN BARREDA-rekin lankidetzan egindako argitalpenak (6)

2017

  1. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats

    Journal of Physiology and Pharmacology, Vol. 68, Núm. 2, pp. 191-199

2016

  1. Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 310, Núm. 11, pp. E925-E937

  2. The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 7, Núm. 1, pp. 79-89

2013

  1. Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting

    American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 304, Núm. 10

2012

  1. Effect of cyclooxygenase-2 inhibition by meloxicam, on atrogin-1 and myogenic regulatory factors in skeletal muscle of rats injected with endotoxin

    Journal of Physiology and Pharmacology, Vol. 63, Núm. 6, pp. 649-659

2011

  1. Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy

    American Journal of Physiology - Endocrinology and Metabolism, Vol. 300, Núm. 5